Inactive Instrument

Analyst Reco. Halyard Health Inc Nyse

Equities

US40650V1008

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

KeyBanc Downgrades Avanos Medical to Sector Weight From Overweight on 'Uncertain' Near-Term Outlook, Lack of Upside Catalysts	23-07-25	MT
CL King Initiates Avanos Medical at Buy Rating With $31 Price Target	23-05-22	MT
Morgan Stanley Adjusts Avanos Medical's Price Target to $26 From $28, Keeps Underweight Rating	23-05-04	MT
Morgan Stanley Adjusts Price Target on Avanos Medical to $28 From $26, Maintains Underweight Rating	23-02-22	MT
Morgan Stanley Adjusts Price Target on Avanos Medical to $26 From $24, Maintains Underweight Rating	23-01-06	MT
KeyBanc Adjusts Avanos Medical' Price Target to $34 From $38, Keeps Overweight Rating	22-11-03	MT
Morgan Stanley Adjusts Avanos Medical's Price Target to $24 From $28, Reiterates Underweight Rating	22-10-11	MT
KeyBanc Adjusts Avanos Medical's Price Target to $38 from $41, Keeps Overweight Rating	22-08-10	MT
Stifel Nicolaus Adjusts Avanos Medical's Price Target to $28 From $37, Maintains Hold Rating	22-07-18	MT
Morgan Stanley Adjusts Price Target on Avanos Medical to $28 From $33, Maintains Underweight Rating	22-07-15	MT
Morgan Stanley Adjusts Avanos Medical's Price Target to $33 from $36, Keeps Underweight Rating	22-05-05	MT
KeyBanc Adjusts Avanos Medical's Price Target to $41 From $47, Maintains Overweight Rating	22-02-24	MT
Berenberg Bank Terminates Coverage on a Number of Companies Due to Analysts' Departures From the Firm	21-12-13	MT
AVANOS MEDICAL : Morgan Stanley Adjusts Price Target on Avanos Medical to $41 From $45, Maintains Underweight Rating	21-08-04	MT
AVANOS MEDICAL : Berenberg Bank Adjusts Avanos Medical PT to $45 From $50, Maintains Buy Rating	21-08-04	MT
AVANOS MEDICAL : Stephens Cuts Avanos Medical to Equal-Weight From Overweight, Price Target to $45 From $60	21-08-04	MT
AVANOS MEDICAL : KeyBanc Adjusts Avanos Medical's Price Target to $47 From $55, Keeps Overweight Rating	21-08-04	MT
AVANOS MEDICAL : Morgan Stanley Adjusts Avanos Medical's Price Target to $45 from $36, Keeps Underweight Rating	20-12-15	MT
AVANOS MEDICAL : KeyBanc Adjusts Avanos Medical's Price Target to $47 From $43, Keeps at Overweight	20-11-04	MT
AVANOS MEDICAL : Morgan Stanley Adjusts Avanos Medical's Price Target to $36 From $31, Keeps Underweight Rating	20-11-04	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Halyard Health Inc Nyse

Equities

US40650V1008

Analyst Reco.

Filters